Pfizer Invests $43B in New Cancer Drug Deal
- Finance
- 15/03/2023
Pfizer is deploying its financial resources to accelerate the battle against cancer, having signed a $43 billion agreement to buy cancer drugmaker Seagen. Their goal is to reach deeper into new...
READ MORE